Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

Recruiting now

Conditions studied: Ascites Hepatic, Liver Failure, Cirrhosis, Liver

In brief

The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.

Key facts

Study ID

NCT06224023

Run by

Carol Davila University of Medicine and Pharmacy

People needed

30

Starts

2024-08-01

Expected to finish

2024-12-31

Last updated by the study team

2024-08-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patient with ascites and chronic liver failure
• no contraindications and technical possibility to perform diagnostic paracentesis
• age above 18 years old
• informed consent

You may not qualify if…

• contraindications to paracentesis or technical impossibility to perform paracentesis
• absence of informed consent

Where it is running

• "Agrippa Ionescu" Hospital — Bucharest, Romania (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.